Outcomes Research in Chronic Viral Hepatitis C: Effects of Interferon Therapy

Outcomes Research in Chronic Viral Hepatitis C: Effects of Interferon Therapy

Saved in:

Bibliographic Details
Main Authors:	Herbert L Bonkovsky, J Michael Woolley
Format:	Article
Language:	English
Published:	Wiley 2000-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2000/127317
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

ASSOCIATIONS OF INTERFERON GENE POLYMORPHISMS OAS-1, OAS-3, PKR WITH CHRONIC VIRAL HEPATITIS C
by: V. A. Bychkov, et al.
Published: (2014-07-01)

Oxidative Stress in Chronic Hepatitis C: The Effect of Interferon Therapy and Correlation with Pathological Features
by: Fátima Serejo, et al.
Published: (2003-01-01)

Epidemiological Differences of Chronic Viral Hepatitis C in Caucasian and Asian Races Taking into Account Population Interferon Gene Polymorphism
by: S. I. Malov, et al.
Published: (2015-06-01)

Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
by: Fang Wei, et al.
Published: (2014-01-01)

Economic burden of chronic viral hepatitis C
by: R. A. Yakhina, et al.
Published: (2022-01-01)

Analysis of the combined effect of polymorphisms interferon genes OAS1, OAS3, PKR, IFNA17 and IFNG in susceptibility to chronic viral hepatitis C
by: V. A. Bychkov, et al.
Published: (2011-06-01)

Diagnostic markers of hepatic steatosis in patients with chronic viral hepatitis C
by: V. V. Tsvetkov, et al.
Published: (2023-05-01)

The feasibility of pathogenetic therapy for chronic viral hepatitis C in adult HIV-infected patients
by: E. B. Bun'kova, et al.
Published: (2024-09-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-α Therapy for Chronic Hepatitis C
by: Huy A. Tran, et al.
Published: (2009-01-01)

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon
by: Jane D Collier, et al.
Published: (2000-01-01)

Dna damage in lymphocytes in chronic viral hepatitis B, C
by: A. O. Mikhailov, et al.
Published: (2017-06-01)

Dynamics of Interferon-G and Interleukine-4 levels in serum of patients with chronic hepatitis C with mixed cryoglobulinemia on the background of immunomodulatory therapy
by: O. P. Mashko, et al.
Published: (2012-12-01)

Hepatitis C Virus Infection: Looking for Interferon Free Regimens
by: J. González-Moreno, et al.
Published: (2013-01-01)

ETIOTROPIC THERAPY OF VIRAL HEPATITIS
by: S. B. Chuelov, et al.
Published: (2017-09-01)

Does a Rapid Decline in the Hematological and Biochemical Parameters Induced by Interferon and Ribavirin Combination Therapy for the Hepatitis C Virus Predict a Sustained Viral Response?
by: Christian Turbide, et al.
Published: (2008-01-01)

Interferon-induced parkinsonism in a patient with chronic hepatitis C Parkinsonismo induzido pelo uso de interferon em paciente com hepatite C crônica
by: Carlos Mauricio Oliveira de Almeida, et al.
Published: (2009-09-01)

PHARMACOECONOMIC ASSESSMENT OF USING INTERFERON-FREE REGIMENS FOR CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATION
by: A. A. Sukhoruk, et al.
Published: (2016-06-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Quality of life and adherence to treatment of patients with chronic viral hepatitis C
by: R. S. Mirkhaydarov, et al.
Published: (2018-04-01)

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
by: Sylvia Drazilova, et al.
Published: (2016-01-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Interferon-Based Hepatitis C Antiviral Treatment Outcomes May Be Predicted by Alanine Aminotransferase Levels
by: Erin Kelly, et al.
Published: (2015-01-01)

Cardiac hemodynamic disorders in patients with active chronic viral hepatitis and the effectiveness of antiviral therapy
by: M. V. Chistyakova, et al.
Published: (2020-12-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Effects of interferon-alpha treatment on the incidence of hyperglycemia in chronic hepatitis C patients: a systematic review and meta-analysis.
by: Wei Zhang, et al.
Published: (2012-01-01)

Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Comparative analysis of vitamin D contents in patients with chronic viral hepatitis C and healthy.
by: L. L. Shostakovych-Koretskaya, et al.
Published: (2019-12-01)

Interferon-Alpha-Induced Changes in Metallothionein Expression in Liver Biopsies from Patients with Chronic Hepatitis C
by: Takeaki Nagamine, et al.
Published: (2005-01-01)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01)

Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
by: Joana Vasconcelos, et al.
Published: (2022-01-01)

METABOLIC AND CARDIOVASCULAR COMORBIDITIES IN BULGARIAN PATIENTS WITH CHRONIC VIRAL B AND C HEPATITIS
by: Radoslava Tsrancheva, et al.
Published: (2025-01-01)

Thrombocytopenia in end-stage renal disease and chronic viral hepatitis B or C
by: Olga Hilda Orasan, et al.
Published: (2018-10-01)

The efficiency of interferon therapy for acute respiratory viral infections in young children
by: T. K. Chudakova, et al.
Published: (2020-03-01)

Problematic issues of the effectiveness of treatment of patients with chronic viral hepatitis C according to the State program and the ways of their solution.
by: L. R. Shostakovych-Koretska, et al.
Published: (2018-11-01)